UnknownNot applicableNCT05914727
Biomarkers Of Lung InVolvement In ASMD
Studying Acid sphingomyelinase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eline C. B. Eskes
- Principal Investigator
- Carla EM Hollak, MD, PhD, profAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Intervention
- eNose(diagnostic_test)
- Enrollment
- 68 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2022 – 2024
Study locations (1)
- Amsterdam UMC, Amsterdam, North Holland, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05914727 on ClinicalTrials.govOther trials for Acid sphingomyelinase deficiency
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT07274826Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)Sohag University
- RECRUITINGNCT06192576A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)Sanofi
- ENROLLING BY INVITATIONNANCT05368038ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramAlbert Einstein College of Medicine